Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Cognitive Behavioral Therapy for Pathological Gambling
This study is currently recruiting participants.
Verified by University of Minnesota, September 2008
Sponsors and Collaborators: University of Minnesota
National Institute of Mental Health (NIMH)
Information provided by: University of Minnesota
ClinicalTrials.gov Identifier: NCT00337753
  Purpose

The purpose of the study is to evaluate a new form of counseling for pathological gambling and to see if the counseling is more effective than attending Gamblers Anonymous.


Condition Intervention Phase
Pathological Gambling
Behavioral: Cognitive Behavioral Therapy
Phase II

MedlinePlus related topics: Compulsive Gambling
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Cognitive Behavioral Therapy for Pathological Gambling

Further study details as provided by University of Minnesota:

Primary Outcome Measures:
  • PG-YBOCS [ Time Frame: At each visit prior to and after therapy has been completed ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Time spent gambling [ Time Frame: At each visit prior to and after therapy has been completed ] [ Designated as safety issue: No ]

Estimated Enrollment: 70
Study Start Date: June 2006
Estimated Study Completion Date: December 2008
Estimated Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Cognitive Behavioral Therapy
    5-weeks of Cognitive Behavioral Therapy
Detailed Description:

Subjects will be assigned to counseling or be given a referral list of available Gamblers Anonymous meetings at the first visit based on answers to questions. Assignment to counseling or Gamblers Anonymous will be randomly selected (i.e. chance) with an equal chance of receiving either one. For those assigned to counseling, you will meet with the therapist for 60 minutes weekly. You will receive 5 sessions of counseling.

All subjects will be assessed with gambling questionnaires twice during the 5-week period and again at 3 and 6 months following the 5-week period.

For those assigned to Gamblers Anonymous, they will be offered 5 weeks of counseling at the end of the 6-month follow-up.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Outpatient men and women age 18 to 75
  2. Presence of current DSM-IV pathological gambling for at least 6 months duration
  3. PG is the most problematic psychiatric disorder (in the patient's and clinician's opinion) and the primary reason for seeking treatment
  4. Minimum score of >5 on the South Oaks Gambling Screen which reflects gambling severity consistent with pathological gambling

Exclusion Criteria:

  1. Current clinically significant suicidality, severe depression (a score of ≥ 19 on the Hamilton Rating Scale for Depression, 17-item version)(30) or any other disorder requiring immediate intervention
  2. Presence of any clinical features requiring a higher level of care than outpatient treatment
  3. Cognitive impairment that interferes with the capacity to engage in CBT or to provide informed consent
  4. DSM-IV substance abuse or dependence within the past 3 months (see Screening Visit)
  5. Current Axis I diagnosis of bipolar disorder or psychotic disorder
  6. Previous treatment of CBT for PG (duration of at least 6 sessions); because CBT is not widely used for PG, a minimum of 6 treatments will be rare.
  7. Current use of psychotropic medications or within 2 months prior to study entry.
  8. Current participation in Gambler's Anonymous (GA).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00337753

Contacts
Contact: Jon E Grant, MD, JD 612-273-9736 grant045@umn.edu
Contact: Brian L Odlaug, BA 612-627-4363 odla0019@umn.edu

Locations
United States, Minnesota
University of Minnesota Medical Center Recruiting
Minneapolis, Minnesota, United States, 55454
Contact: Brian L Odlaug, BA     612-627-4363     odla0019@umn.edu    
Sponsors and Collaborators
University of Minnesota
Investigators
Principal Investigator: Jon E Grant, MD, JD University of Minnesota
  More Information

Responsible Party: University of Minnesota ( Jon E. Grant )
Study ID Numbers: 0503M68191
Study First Received: June 14, 2006
Last Updated: September 8, 2008
ClinicalTrials.gov Identifier: NCT00337753  
Health Authority: United States: Institutional Review Board

Keywords provided by University of Minnesota:
Gambling

Study placed in the following topic categories:
Impulse Control Disorders
Gambling
Mental Disorders

ClinicalTrials.gov processed this record on January 16, 2009